1 |
15 or 45 mg |
- |
- |
- |
- |
067 [1] 67 💬 |
2 |
30 or 60 mg |
- |
- |
- |
- |
067 [1] 67 💬 |
3 |
30 or 90 mg |
- |
- |
- |
- |
067 [1] 67 💬 |
4 |
[metformina] |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
067 [1] 67 💬 |
5 |
[tol |
- |
- |
- |
- |
067 [1] 67 💬 |
6 |
[tolvaptan 15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
7 |
[tolvaptan 30] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
8 |
[tolvaptan 45/15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
9 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
10 |
Al |
- |
- |
- |
- |
005 [9] 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
11 |
Amias |
- |
- |
- |
- |
067 [1] 67 💬 |
12 |
Aminohippurate |
Aminohippuric acid |
[2] D01421 D01421, D06890 D06890 💬 |
- |
- |
067 [1] 67 💬 |
13 |
Aminohippurate sodium inj 20% |
Aminohippuric acid |
[2] D01421 D01421, D06890 D06890 💬 |
- |
- |
067 [1] 67 💬 |
14 |
Amlodipine |
Amlodipine |
[3] D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 67, 298 💬 |
15 |
Anti-hypertensive medications |
- |
- |
- |
- |
067 [1] 67 💬 |
16 |
Antihypertensive drugs |
- |
- |
- |
- |
067 [1] 67 💬 |
17 |
Aprinox |
- |
- |
- |
- |
067 [1] 67 💬 |
18 |
Arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
046 [9] 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
19 |
Bardoxolone |
Bardoxolone |
[1] D09584 D09584 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
20 |
Bardoxolone methyl |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
21 |
Bardoxolone methyl 10 mg |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
22 |
Bardoxolone methyl 15 mg |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
23 |
Bardoxolone methyl 20 mg |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
24 |
Bardoxolone methyl 5 mg |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
25 |
Bardoxolone methyl capsules |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [4] 66, 67, 86, 222 💬 |
26 |
Bardoxolone methyl oral capsule |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
27 |
Behavioral: diet and water adjustment |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
28 |
Bendroflumethiazide |
Bendroflumethiazide |
[1] D00650 D00650 💬 |
- |
- |
067 [1] 67 💬 |
29 |
Bim 23014 |
- |
- |
- |
- |
067 [1] 67 💬 |
30 |
Bisoprolol |
Bisoprolol |
[2] D00634 D00634, D02342 D02342 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [3] 67, 86, 113 💬 |
31 |
Bosutinib |
Bosutinib |
[1] D03252 D03252 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
002 [2] 2 , 67 💬 |
32 |
Bosutinib (anhydrous) |
Bosutinib |
[1] D03252 D03252 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
067 [1] 67 💬 |
33 |
C03xa01 |
- |
- |
- |
- |
067 [2] 67, 72 💬 |
34 |
Calcineurin inhibitors maintenance |
- |
- |
- |
- |
067 [1] 67 💬 |
35 |
Candesartan |
Candesartan |
[1] D00522 D00522 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [2] 58, 67 💬 |
36 |
Candesartan and cilnidipine |
Candesartan |
[2] D00522 D00522, D01173 D01173 💬 |
AGTR1 [6] AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
AGE-RAGE signaling pathway in diabetic complications [48] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [1] 67 💬 |
37 |
Candesartan plus non-ccb agents |
Candesartan |
[1] D00522 D00522 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
067 [1] 67 💬 |
38 |
Cardura |
- |
- |
- |
- |
067 [1] 67 💬 |
39 |
Certican |
- |
- |
- |
- |
067 [4] 67, 96, 158, 228 💬 |
40 |
Certican tabletten |
- |
- |
- |
- |
067 [1] 67 💬 |
41 |
Cilnidipine |
Cilnidipine |
[1] D01173 D01173 💬 |
CACNA1B [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [40] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [1] 67 💬 |
42 |
Conventional therapy |
- |
- |
- |
- |
067 [2] 67, 222 💬 |
43 |
Curcumin |
Curcumin |
- |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
44 |
Doxazosin |
Doxazosin |
[2] D00608 D00608, D07874 D07874 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [2] 57, 67 💬 |
45 |
Emodin |
Emodin |
- |
- |
- |
067 [1] 67 💬 |
46 |
Equal |
- |
- |
- |
- |
006 [5] 6 , 13, 67, 86, 230 💬 |
47 |
Everolimus |
Everolimus |
[1] D02714 D02714 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
034 [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 |
48 |
G1117337 |
- |
- |
- |
- |
067 [2] 67, 299 💬 |
49 |
Genz-682452 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
50 |
Genz-682452-au |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
51 |
Glpg2737 |
- |
- |
- |
- |
067 [2] 67, 299 💬 |
52 |
Gz402671 |
- |
- |
- |
- |
019 [2] 19, 67 💬 |
53 |
Hct |
- |
- |
- |
- |
067 [1] 67 💬 |
54 |
High water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
55 |
Hydralazine |
Hydralazine |
[2] D01302 D01302, D08044 D08044 💬 |
AOC3 [1] AOC3 💬 |
Glycine, serine and threonine metabolism [5] Glycine, serine and threonine metabolism, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism |
067 [1] 67 💬 |
56 |
Hydrochlorothiazide |
Hydrochlorothiazide |
[1] D00340 D00340 💬 |
- |
- |
013 [4] 13, 67, 225, 235 💬 |
57 |
Imidapril |
Imidapril |
[1] D08068 D08068 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
067 [1] 67 💬 |
58 |
Intravenous injection autologous mesenchymal stem cells |
- |
- |
- |
- |
067 [1] 67 💬 |
59 |
Iohexol |
Iohexol |
[1] D01817 D01817 💬 |
- |
- |
019 [2] 19, 67 💬 |
60 |
Iohexol inj 300 milligrams per milliliter (mg/ml) |
Iohexol |
[1] D01817 D01817 💬 |
- |
- |
067 [1] 67 💬 |
61 |
Istin |
- |
- |
- |
- |
067 [1] 67 💬 |
62 |
Jinarc |
- |
- |
- |
- |
067 [1] 67 💬 |
63 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
64 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
65 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
66 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
67 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
68 |
Jinarc - tolvaptan tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
69 |
Jinarc 15 mg tablets, jinarc 45 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
70 |
Jinarc 30 mg tablets, 90 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
71 |
Jinarc 30 mg tablets, jinarc 60 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
72 |
Jinarc® 15mg tablet |
- |
- |
- |
- |
067 [1] 67 💬 |
73 |
Jinarc® 30 tablet |
- |
- |
- |
- |
067 [1] 67 💬 |
74 |
Kd019 (tesevatinib) |
Tesevatinib |
[1] D11772 D11772 💬 |
EGFR [5] EGFR, EPHB4, ERBB2, FLT4, KDR 💬 |
Adherens junction [51] Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway |
067 [1] 67 💬 |
75 |
Lanreotide |
Lanreotide |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
76 |
Lanreotide acetate |
Acetate |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
77 |
Lisinopril |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 49, 66, 67, 113, 222 💬 |
78 |
Lixivaptan |
Lixivaptan |
[1] D04752 D04752 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
79 |
Long-acting somatostatin |
Somatostatin |
[1] D07431 D07431 💬 |
SSTR1 [5] SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [1] 67 💬 |
80 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
81 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
82 |
Metformina |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
067 [2] 67, 113 💬 |
83 |
Monocor |
- |
- |
- |
- |
067 [1] 67 💬 |
84 |
Ng-monomethyl-l-arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
067 [1] 67 💬 |
85 |
Ng-monomethyl-l-arginine (drug) |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
067 [1] 67 💬 |
86 |
Niacinamide |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
005 [4] 5 , 6 , 13, 67 💬 |
87 |
Octeotride |
- |
- |
- |
- |
067 [1] 67 💬 |
88 |
Octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [7] 67, 75, 84, 85, 89, 193, 227 💬 |
89 |
Octreotide lar |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 227 💬 |
90 |
Octreotide-lar |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [1] 67 💬 |
91 |
Opc-41061 |
- |
- |
- |
- |
067 [1] 67 💬 |
92 |
Opc-41061 (tolvaptan) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
93 |
Other: ad libitum water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
94 |
Other: high water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
95 |
Other: low blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
96 |
Other: saline solution |
- |
- |
- |
- |
067 [1] 67 💬 |
97 |
Other: saline solution. |
- |
- |
- |
- |
067 [1] 67 💬 |
98 |
Other: standard |
- |
- |
- |
- |
067 [1] 67 💬 |
99 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
100 |
Other: water |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
101 |
Other: water prescription |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
102 |
Pasireotide |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [3] 67, 74, 75 💬 |
103 |
Pasireotide lar |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 75 💬 |
104 |
Pf-05208763 |
- |
- |
- |
- |
067 [1] 67 💬 |
105 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
106 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
107 |
Potassium |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
036 [10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
108 |
Pravastatin |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
109 |
Procedure: renal sympathetic denervation |
- |
- |
- |
- |
067 [1] 67 💬 |
110 |
Protein |
- |
- |
- |
- |
046 [2] 46, 67 💬 |
111 |
Rad001 |
- |
- |
- |
- |
034 [6] 34, 67, 89, 96, 158, 228 💬 |
112 |
Radiation: pet/ct scan |
- |
- |
- |
- |
067 [1] 67 💬 |
113 |
Ramipril |
Ramipril |
[1] D00421 D00421 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 [7] 46, 49, 66, 67, 113, 218, 257 💬 |
114 |
Rapamune |
- |
- |
- |
- |
002 [8] 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
115 |
Rapamune 1mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
116 |
Rapamune*100cpr riv 1mg |
- |
- |
- |
- |
067 [1] 67 💬 |
117 |
Rapamune*30cpr riv 1mg |
- |
- |
- |
- |
067 [1] 67 💬 |
118 |
Rapamune*30cpr riv 2mg |
- |
- |
- |
- |
067 [1] 67 💬 |
119 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
120 |
Rgls4326 |
- |
- |
- |
- |
067 [1] 67 💬 |
121 |
Rta 402 |
- |
- |
- |
- |
067 [3] 67, 86, 218 💬 |
122 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
123 |
Samsca |
- |
- |
- |
- |
067 [2] 67, 72 💬 |
124 |
Samsca 15 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
125 |
Samsca 30 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
126 |
Sandostatin lar |
- |
- |
- |
- |
067 [4] 67, 84, 193, 227 💬 |
127 |
Sandostatina |
- |
- |
- |
- |
067 [1] 67 💬 |
128 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 [1] 67 💬 |
129 |
Sandostatina lar |
- |
- |
- |
- |
067 [1] 67 💬 |
130 |
Sandostatina lar im fl 20mg +2f |
- |
- |
- |
- |
067 [1] 67 💬 |
131 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 [3] 6 , 19, 67 💬 |
132 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
133 |
Ski-606 |
- |
- |
- |
- |
067 [1] 67 💬 |
134 |
Sodium citrate |
Sodium citrate |
[2] D01781 D01781, D05855 D05855 💬 |
- |
- |
067 [4] 67, 214, 215, 235 💬 |
135 |
Sodiumchloride |
- |
- |
- |
- |
067 [1] 67 💬 |
136 |
Somatostatin |
Somatostatin |
[1] D07431 D07431 💬 |
SSTR1 [5] SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 78 💬 |
137 |
Somatuline |
- |
- |
- |
- |
067 [2] 67, 298 💬 |
138 |
Somatuline autogel |
- |
- |
- |
- |
067 [1] 67 💬 |
139 |
Somatuline autosolution |
- |
- |
- |
- |
067 [1] 67 💬 |
140 |
Spironolactone |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
141 |
Sugar pill |
- |
- |
- |
- |
005 [8] 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
142 |
Telmisartan |
Telmisartan |
[1] D00627 D00627 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 67 💬 |
143 |
Tesevatinib |
Tesevatinib |
[1] D11772 D11772 💬 |
EGFR [5] EGFR, EPHB4, ERBB2, FLT4, KDR 💬 |
Adherens junction [51] Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway |
067 [1] 67 💬 |
144 |
Tetracosactin |
- |
- |
- |
- |
067 [1] 67 💬 |
145 |
Tolvaptan |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [3] 67, 72, 225 💬 |
146 |
Tolvaptan (opc-41061) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
147 |
Tolvaptan 15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
148 |
Tolvaptan 15 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
149 |
Tolvaptan 15 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
150 |
Tolvaptan 15mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
151 |
Tolvaptan 30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
152 |
Tolvaptan 30 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
153 |
Tolvaptan 30 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
154 |
Tolvaptan 30mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
155 |
Tolvaptan 45/15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
156 |
Tolvaptan 60/30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
157 |
Tolvaptan 7.5 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
158 |
Tolvaptan ir |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
159 |
Tolvaptan mr |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
160 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 [8] 46, 66, 67, 96, 162, 222, 224, 271 💬 |
161 |
Tripterygium wilfordii |
Tripterygium wilfordii whole |
- |
- |
- |
046 [6] 46, 66, 67, 222, 224, 271 💬 |
162 |
Triptolide |
Triptolide |
- |
- |
- |
067 [1] 67 💬 |
163 |
Triptolide-containing formulation |
Triptolide |
- |
- |
- |
067 [1] 67 💬 |
164 |
Udca |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
067 [5] 67, 93, 94, 97, 296 💬 |
165 |
Unknown |
- |
- |
- |
- |
067 [2] 67, 97 💬 |
166 |
Ursochol |
- |
- |
- |
- |
067 [1] 67 💬 |
167 |
Ursochol 300 |
- |
- |
- |
- |
067 [1] 67 💬 |
168 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
006 [8] 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
169 |
Venglustat |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
170 |
Venglustat gz/sar402671 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
067 [1] 67 💬 |
171 |
Venglustat gz402671 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
019 [2] 19, 67 💬 |
172 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
173 |
Zestril |
- |
- |
- |
- |
019 [3] 19, 67, 222 💬 |
174 |
Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al |
- |
- |
- |
- |
067 [1] 67 💬 |